Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
15 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
INFECTIEZIEKTEN IEPER from Ieper, company number BE1001694650, closed financial year 2025 with a result of € 0 after tax. For that financial year INFECTIEZIEKTEN IEPER recorded a gross margin of € -2,939 and equity of € 5,000. Compared with financial year 2024, the result moved from € 0 to € 0. Around break-even. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.
€ 5,000
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 0
Profit after tax over the fiscal year.
€ 235,916
▲ 43% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 0.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 157,301
▲ 45% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,999
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € -346 | € -2,939 | ▼ € 2,593 |
| Equity | € 5,000 | € 5,000 | |
| Total debts | € 516,656 | € 744,043 | ▲ 44% |
| Cash | € 165,515 | € 235,916 | ▲ 43% |
| Balance sheet total | € 521,656 | € 749,043 | ▲ 44% |
Key figures of INFECTIEZIEKTEN IEPER, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to INFECTIEZIEKTEN IEPER?
What happened at INFECTIEZIEKTEN IEPER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 0. Source: NBB ↗
- New establishment in Ieper. KBO
- Start of the company according to the CBE. KBO
In short
From € 0 profit in 2024 to € 0 profit in 2025.
Paid € 1,440 in corporate taxes since 2024.
Management
The stake of DR. TERRYN WIM comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
INFECTIEZIEKTEN IEPERBehind INFECTIEZIEKTEN IEPER are DR. TERRYN WIM BV and DR. KELLY DE SCHUYTER BV. The shares are held by DR. TERRYN WIM (100%).
Directors
According to the 2025 annual accounts
Managing director · represented by Kelly DE SCHUYTER
Also active at: NEFROLOGIE IEPER
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Briekestraat 12
8900 Ieper
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 15 companies are registered at this address.
All companies at this address →Vereniging Onze-Lieve-Vrouweziekenhuis
Jan Yperman Ziekenhuis
KLOPPEND HART
Associatie Klinische Biologie Jan Yperman
MKA WESTHOEK
+10 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1001.694.650
- VAT number
- BE 1001.694.650
- Registered office
- Briekestraat 12, 8900 Ieper
- Names & denominations
- INFECTIEZIEKTEN IEPER
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 October 2023
- Peppol
- Active · Active since 17 Jul 2026
- Activities · NACE
Activiteiten van medisch specialisten
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige vormen van onderwijs
Overige zakelijke dienstverlening, neg
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied